MTOR and Spinocerebellar ataxia type 3: We proposed that the small molecule n-BP, functioning as mTOR inhibition, can ameliorate the progressive pathogenesis of SCA3 through the promotion of autophagy to eliminate the abnormal aggregates, thereby preventing the loss of Purkinje cells in the cerebellum.